Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Finasteride may worsen blood sugar control in diabetic patients.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Finasteride effectively reduces prostate size in dogs with benign prostatic hyperplasia at a low, safe dose.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

More research needed to confirm finasteride as standard treatment for FFA.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Finasteride may help prevent prostate cancer.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.